Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-3-16
pubmed:abstractText
To investigate whether anti-TNF therapy could have an effect on dendritic cells (DCs) and regulatory T cells in rheumatoid arthritis (RA) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16539816-Adult, pubmed-meshheading:16539816-Aged, pubmed-meshheading:16539816-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16539816-Antibodies, Monoclonal, pubmed-meshheading:16539816-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16539816-Arthritis, Rheumatoid, pubmed-meshheading:16539816-Cell Separation, pubmed-meshheading:16539816-Cytokines, pubmed-meshheading:16539816-Dendritic Cells, pubmed-meshheading:16539816-Drug Therapy, Combination, pubmed-meshheading:16539816-Female, pubmed-meshheading:16539816-Flow Cytometry, pubmed-meshheading:16539816-Humans, pubmed-meshheading:16539816-Lymphocyte Activation, pubmed-meshheading:16539816-Male, pubmed-meshheading:16539816-Methotrexate, pubmed-meshheading:16539816-Middle Aged, pubmed-meshheading:16539816-Severity of Illness Index, pubmed-meshheading:16539816-T-Lymphocytes, Regulatory, pubmed-meshheading:16539816-Treatment Outcome, pubmed-meshheading:16539816-Tumor Necrosis Factor-alpha
pubmed:articleTitle
Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
pubmed:affiliation
Department of Immunology, Allergology and Rheumatology, University of Antwerp, Belgium.
pubmed:publicationType
Journal Article